Alnylam Pharmaceuticals | Principal Empresa de Terapia de RNAi | Brasil
A Alnylam está liderando a tradução da Interferência de RNA (RNAi) em uma classe de medicamentos totalmente inovadora, que acreditamos ter o potencial de transformar a vida de pacientes acometidos por doenças genéticas e raras.
Sprache: Portugiesisch
Alnylam is leading the translation of RNA interference (RNAi) into a innovative, entirely new class of medicines which we believe have the potential to transform the lives of patients who are living with rare and genetic diseases.
Learn about Alnylam Pharmaceuticals, RNAi therapeutics, and the company's efforts in treating amyloidosis, hyperoxaluria, and porphyria.
Together we redefine healthcare by connecting the dots. Legal + strategy consulting for healthcare and life sciences.
meta home desc
Max-Planck-Innovation ist verantwortlich für den Technologietransfer der Institute der Max-Planck-Gesellschaft, Deutschlands führender Forschungsorganisation für Grundlagenforschung.
Alnylam conduit la transformation de l'interférence ARN (ARNi) en une classe de médicaments innovante, totalement nouvelle qui, selon nous, a le potentiel de transformer la vie des patients atteints d'une maladie génétique rare.
Saiba mais sobre a apneia do sono, ronco e doenças respiratórias: causas, sintomas e soluções de tratamento para pacientes da ResMed.
Tratamento de dores crônicas, Quiropraxia, Terapia de pontos gatilho, Terapia neural, Hipertensão arterial, Diabetes mellitus Hiperlipidemia, Síndrome
Único representante no Brasil do Upledger Institute Inc®, tendo como meta divulgar no país o trabalho do Dr. John E. Upledger: a Terapia CranioSacral e a Liberação SomatoEmocional.
SAE Media Group is a highly professional, global company that specialises in the production of Business-to-Business Conferences, Workshops and Masterclasses. Part of the SAE Media Group, SMi researches, creates and delivers events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical sectors.
Pioneering the discovery and development of RNA-based therapeutics designed to prevent, repair and reverse diseases of the heart.
Matérias sobre Liderança, Gestão, Bem-estar, Psicologia e Atualidades
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.